Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.

AIDS (London, England) - 12 Nov 1998

Bratt G, Karlsson A, Leandersson A C, Albert J, Wahren B, Sandström E

Abstract excerpt

BACKGROUND: The efficacy of highly active antiretroviral treatment (HAART) in HIV-1 disease may vary between nucleoside-naive and experienced patients as well as between patients with different viral phenotypes and in different stages of disease. OBJECTIVE: To investigate variables of importance for successful long-term viral suppression by analysing virological, clinical and immunological characteristics at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Infections

Share to Longitudinal Studies

Share to Regression Analysis

Share to RNA, Viral

Source

Identifiers

PMID: 9833861
DOI: 10.1097/00002030-199816000-00015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.PMID 9833861Read ↗

Association between CCR5 genotype and the clinical course of HIV-1 infection.Semantic proximity Read ↗

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.Semantic proximity Read ↗

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.Semantic proximity Read ↗

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.Semantic proximity Read ↗

Genetic factors that confer sensitivity to HAART in HIV-infected subjects: implication of a benefit of an earlier initiation of HAART.Semantic proximity Read ↗

Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.Semantic proximity Read ↗

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.Semantic proximity Read ↗

CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.Semantic proximity Read ↗

MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.Semantic proximity Read ↗

Efficacy of initial antiretroviral therapy for HIV-1 infection in adults: a systematic review and meta-analysis of 114 studies with up to 144 weeks' follow-up.Semantic proximity Read ↗

Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.Semantic proximity Read ↗

Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.